ABBV
AbbVie Inc
264.40$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.4% | 24.5% | 26.1% | 23.8% | 19.4% | 18.9% | 20.3% | 21.3% | 21.3% | 21.7% | 24.6% | 24.9% | |
| 9.8% | 9.5% | 12.1% | 9.3% | 5.1% | 4.1% | 3.8% | 4.7% | 4.2% | 3.9% | 6.9% | 4.9% | |
| 9.8% | 9.5% | 12.1% | 9.3% | 5.1% | 4.1% | 3.8% | 4.7% | 4.2% | 3.9% | 6.9% | 4.9% | |
| 8.4% | 8.3% | 8.0% | 8.3% | 8.0% | 8.1% | 9.2% | 9.2% | 9.5% | 9.4% | 9.1% | 10.2% | |
| 2.9% | 3.0% | 2.9% | 3.0% | 3.1% | 3.1% | 3.3% | 3.6% | 3.7% | 3.7% | 3.7% | 3.8% | |
| 3.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 23.6% | 24.0% | 22.5% | 23.5% | 24.6% | 25.9% | 25.9% | 26.0% | 26.6% | 26.6% | 26.1% | 26.3% | |
| 43.0% | 41.3% | 41.8% | 42.4% | 46.5% | 44.4% | 43.0% | 41.6% | 40.6% | 39.3% | 37.3% | 36.4% | |
| 91.1% | 92.3% | 94.6% | 95.2% | 95.8% | 97.5% | 98.9% | 100.1% | 101.9% | 102.4% | 104.8% | 104.3% | |
| 25.5% | 28.1% | 27.9% | 29.5% | 30.0% | 28.7% | 26.7% | 29.0% | 29.4% | 32.3% | 30.9% | 30.8% | |
| 3.8% | 5.3% | 6.8% | 8.9% | 8.8% | 5.0% | 3.9% | 5.5% | 4.3% | 6.4% | 6.1% | 6.2% | |
| 21.7% | 2.7% | 21.0% | 20.6% | 21.2% | 23.6% | 22.7% | 23.2% | 24.9% | 25.7% | 24.6% | 24.5% | |
| 40.8% | 38.7% | 42.9% | 40.9% | 40.8% | 44.6% | 47.4% | 45.9% | 47.0% | 44.0% | 47.3% | 46.2% | |
| 8.9% | 7.7% | 5.4% | 4.8% | 4.2% | 2.5% | 1.1% | -0.1% | -1.9% | -2.4% | -4.8% | -4.4% | |
| 0.7% | -0.7% | -1.6% | -2.7% | -3.5% | -5.8% | -7.0% | -8.4% | -10.6% | -11.6% | -13.1% | -12.8% | |
| 1.3% | 1.3% | 1.2% | 1.2% | 1.2% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.